Compound 236
Identifiers
- Canonical SMILES:
CN1c2ncnn2[C@H](C2=C1c1ccccc1O[C@@H]2c1ccc(Cl)cc1)c1ccc(Br)cc1
- InChi:
InChI=1S/C25H18BrClN4O/c1-30-23-19-4-2-3-5-20(19)32-24(16-8-12-18(27)13-9-16)21(23)22(31-25(30)28-14-29-31)15-6-10-17(26)11-7-15/h2-14,22,24H,1H3/t22-,24+/m0/s1
- InChiKey:
PQGSGKGNJOWFEG-LADGPHEKSA-N
External links
44549488 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.05 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 504.04 g/mol | |||
HBA | 5 | |||
HBD | 0 | |||
HBA + HBD | 5 | |||
AlogP | 6.34 | |||
TPSA | 43.18 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4540 | BMS-394136 | DB12067 | |
0.3653 | GDC-0927 | DB14934 | |
0.3531 | Parsaclisib | DB14867 | |
0.3418 | LY-2881835 | DB15046 | |
0.3370 | Desvancosaminyl vancomycin | DB04529 | |
0.3345 | Rocaglamide | DB15495 | |
0.3342 | Vancomycin | DB00512 | |
0.3333 | Galicaftor | DB14894 | |
0.3323 | MK-1775 | DB11740 | |
0.3313 | (4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium | DB02673 | |
0.3309 | Didesmethylrocaglamide | DB15496 | |
0.3307 | Cannabichromene | DB14735 | |
0.3301 | Itraconazole | DB01167 | |
0.3299 | Balhimycin | DB04111 | |
0.3290 | Posaconazole | DB01263 |